Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |